CAPLIPOINTNSECAPLIN POINT LAB LTD.HighPositive
Announced Wed, 12 Aug · 13:41 IST

Q1 FY27 results: revenue up 20.7%, final dividend Rs 4/share

Revenue Growth 20pctPat Growth 25pctEbitda Margin ExpansionResults View source PDFExplain this filing

CAPLIPOINT · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
-4.8%1-day move
₹2630.00
prior close
₹2575.00
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-2.9-0.9-1.0-3.3-4.8-5.4-4.0-3.8-2.1-2.3
Up moveDown movePending
AI summary

Caplin Point reported Q1 FY27 consolidated revenue of Rs 644 Cr, up 20.7% YoY, with PAT of Rs 179 Cr, up 18.8% YoY. EBITDA grew 23% to Rs 247 Cr with margin expansion to 38.4%. Board recommended final dividend of Rs 4 per share, taking total FY26 dividend to Rs 8 per share. MD Dr. Sridhar Ganesan re-appointed for 2 years.

Likely market impact

Strong revenue, profit and margin growth. Healthy dividend payout signals confidence. Positive for shareholders.